Methylene blue for management of Ifosfamide-induced encephalopathy.
about
Intraoperative localization of insulinoma and normal pancreas using invisible near-infrared fluorescent light.Oxazaphosphorines: new therapeutic strategies for an old class of drugs.Therapeutic approaches to delay the onset of Alzheimer's diseaseMethylene blue promotes quiescence of rat neural progenitor cells.Fatal Ifosfamide-induced metabolic encephalopathy in patients with recurrent epithelial ovarian cancer: report of two cases.Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease modelsMethylene blue induces macroautophagy through 5' adenosine monophosphate-activated protein kinase pathway to protect neurons from serum deprivationOutpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents.Methylene blue for the treatment of septic shock.Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neurotoxicity.Guidelines for the Establishment of Appropriate Beyond Use Dating of Sterile Compounded Admixtures.Chemotherapy related encephalopathy in a patient with Stage IV cervical carcinoma treated with cisplatin and 5-fluorouracil: a case report.Successful treatment of ifosfamide neurotoxicity with dexmedetomidine.Important role of thiamine in preventing ifosfamide-induced encephalopathy.Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report.Protective effects of caffeic acid phenethyl ester on ifosfamide-induced central neurotoxicity in rats.Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant.Effects of methylene blue on propofol requirement during anaesthesia induction and surgery.Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy.Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue.Enhancement of the binding affinity of methylene blue to site I in human serum albumin by cupric and ferric ions.Ifosfamide associated myoclonus-encephalopathy syndrome.Role of thiamine in managing ifosfamide-induced encephalopathy.
P2860
Q33739396-9F451A02-3194-4BD9-BB13-F7C79891C08DQ34113899-5AFE3BEE-9216-4B00-B4E7-8A7B6BA25BEFQ34172377-433B3197-9A60-4899-B43F-481C59B0D1AAQ34299731-EA5B4E45-C375-49BF-8DAB-0A146C5CD296Q35661073-9D2A41AD-2022-4CD0-BBE5-9971C9A2F89DQ36538885-5B84B706-8EFF-4DD9-97FD-5564F99DFB42Q36812658-2B1FE3A4-FA3E-4F50-9E67-A820CA1DFBFDQ37038352-C1D90D10-10DB-4791-A56F-74BA75C27609Q37767426-8D05D10A-1A68-4B53-9533-E6BF8FFA4E5BQ37791283-701831FD-808E-4E5C-8B3C-9745C7F93B02Q41141251-44C09484-1784-408A-8617-B027184B2A77Q42549776-39ACACEA-0C82-48F6-B57D-029ECFDA2FA9Q43179429-8A9B2D2B-E91B-4D51-A096-CFCBAD28DAE3Q43289491-88BC2117-40E0-4CB2-9801-5AA8F92361F6Q43880501-C4F6821D-6E56-4DE4-AA4A-64BF40BAD92AQ44873968-57551631-4E01-4D0A-8005-28B55028396CQ46417406-767A5017-AD05-49B9-83C6-E5978CA32E9DQ46705804-658FF6AD-3C11-438F-AD18-15D34B7B95CFQ48196500-9D9F7220-22CD-4964-89AA-9E0DC12B6FBBQ49627984-D9CA58A4-EE3A-4908-9604-7EA1631A4A8CQ50215878-20E8AF1B-D32D-44CF-BB54-DA065895C424Q50265352-509539D6-AA7C-4719-B8C4-0FF3BC9AE30BQ50473576-6B160337-8DA2-4AC0-A1F9-71AE4D479BDC
P2860
Methylene blue for management of Ifosfamide-induced encephalopathy.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Methylene blue for management of Ifosfamide-induced encephalopathy.
@ast
Methylene blue for management of Ifosfamide-induced encephalopathy.
@en
Methylene blue for management of Ifosfamide-induced encephalopathy.
@nl
type
label
Methylene blue for management of Ifosfamide-induced encephalopathy.
@ast
Methylene blue for management of Ifosfamide-induced encephalopathy.
@en
Methylene blue for management of Ifosfamide-induced encephalopathy.
@nl
prefLabel
Methylene blue for management of Ifosfamide-induced encephalopathy.
@ast
Methylene blue for management of Ifosfamide-induced encephalopathy.
@en
Methylene blue for management of Ifosfamide-induced encephalopathy.
@nl
P356
P1476
Methylene blue for management of Ifosfamide-induced encephalopathy.
@en
P2093
Priti N Patel
P304
P356
10.1345/APH.1G114
P407
P577
2006-01-03T00:00:00Z